X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (342) 342
Patent (80) 80
Publication (64) 64
Conference Proceeding (5) 5
Book Chapter (2) 2
Dissertation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (181) 181
male (115) 115
hematology (109) 109
female (104) 104
middle aged (97) 97
index medicus (87) 87
aged (85) 85
oncology (85) 85
life sciences (74) 74
adult (71) 71
human necessities (61) 61
hygiene (61) 61
medical or veterinary science (61) 61
chemistry (44) 44
immunology (44) 44
metallurgy (43) 43
organic chemistry (40) 40
preparations for medical, dental, or toilet purposes (40) 40
adolescent (36) 36
treatment outcome (32) 32
aged, 80 and over (30) 30
cancer (30) 30
electric heating (28) 28
electric lighting not otherwise provided for (28) 28
electric techniques not otherwise provided for (28) 28
electricity (28) 28
chemotherapy (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
leukemia (24) 24
specific therapeutic activity of chemical compounds ormedicinal preparations (24) 24
peptides (23) 23
child (22) 22
prognosis (22) 22
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (21) 21
combined modality therapy (21) 21
disinfection, sterilisation, or deodorisation of air (21) 21
materials for bandages, dressings, absorbent pads, or surgicalarticles (21) 21
medicine & public health (21) 21
methods or apparatus for sterilising materials or objects ingeneral (21) 21
remission induction (21) 21
survival (21) 21
mesh : humans (20) 20
rituximab (20) 20
survival analysis (20) 20
[ sdv.imm ] life sciences [q-bio]/immunology (19) 19
hemic and lymphatic diseases (19) 19
in situ hybridization, fluorescence (19) 19
lymphoma (19) 19
risk factors (19) 19
therapy (19) 19
[ sdv ] life sciences [q-bio] (18) 18
analysis (18) 18
animals (18) 18
research (18) 18
follow-up studies (17) 17
heterocyclic compounds (17) 17
expression (16) 16
lymphomas (16) 16
performing operations (16) 16
retrospective studies (16) 16
transporting (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (15) 15
disease-free survival (15) 15
in-situ hybridization (15) 15
transplantation, autologous (15) 15
young adult (15) 15
abridged index medicus (14) 14
child, preschool (14) 14
genetics & heredity (14) 14
multiple myeloma (14) 14
survival rate (14) 14
acute lymphoblastic-leukemia (13) 13
acute myeloid-leukemia (13) 13
antineoplastic agents - therapeutic use (13) 13
apoptosis (13) 13
blasting (13) 13
heating (13) 13
in-vitro (13) 13
lighting (13) 13
mechanical engineering (13) 13
mesh : aged (13) 13
time factors (13) 13
translocation, genetic (13) 13
weapons (13) 13
[sdv.imm]life sciences [q-bio]/immunology (12) 12
care and treatment (12) 12
chromosome aberrations (12) 12
chronic lymphocytic leukemia (12) 12
dairy products, e.g. milk, butter, cheese (12) 12
foods or foodstuffs (12) 12
france (12) 12
hematology, oncology and palliative medicine (12) 12
imatinib mesylate (12) 12
karyotyping (12) 12
making thereof (12) 12
milk or cheese substitutes (12) 12
mutation (12) 12
non-hodgkins-lymphoma (12) 12
precursor cell lymphoblastic leukemia-lymphoma - genetics (12) 12
prospective studies (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (387) 387
French (60) 60
German (18) 18
Spanish (5) 5
Danish (3) 3
Polish (3) 3
Portuguese (3) 3
Chinese (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 26, pp. 2511 - 2521
In this study, adding pegylated interferon alfa-2a to imatinib therapy for chronic myeloid leukemia resulted in a greater reduction in the number of cells... 
CHRONIC MYELOGENOUS LEUKEMIA | CHROMOSOME | MEDICINE, GENERAL & INTERNAL | INTERFERON | CML | ABL TYROSINE KINASE | HEMATOPOIETIC STEM-CELLS | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | QUIESCENT | CYTARABINE | Piperazines - administration & dosage | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Proto-Oncogene Proteins c-abl - analysis | Cytarabine - adverse effects | Recombinant Proteins | RNA, Neoplasm - analysis | Adult | Female | Transcription, Genetic | Neutropenia - chemically induced | Proto-Oncogene Proteins c-abl - genetics | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Anemia - chemically induced | Treatment Outcome | Thrombocytopenia - chemically induced | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Leukemia, Myeloid, Chronic-Phase - mortality | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Stem Cells - drug effects | Interferon-alpha - adverse effects | Benzamides | Drug therapy | Chronic myeloid leukemia | Medical research | Kinases | Leukemia | Manuscripts
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2017, Volume 35, Issue 4, pp. 387 - 393
Purpose Elderly patients with acute myeloid leukemia (AML) have a poor prognosis, and innovative maintenance therapy could improve their outcomes. Androgens,... 
Life Sciences | Hematology | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2004, Volume 350, Issue 13, pp. 1287 - 1295
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2010, Volume 28, Issue 18, pp. 3028 - 3034
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e94965
Journal Article
Blood, ISSN 0006-4971, 01/2009, Volume 113, Issue 5, pp. 995 - 1001
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 20, pp. 2827 - 2832
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 2010, Volume 3, Issue 1, pp. 49 - 49
Journal Article
Clinical reviews in allergy & immunology, ISSN 1080-0549, 05/2019, pp. 1 - 17
Approved for the treatment of autoimmune diseases, hematological malignancies, and solid cancers, several monoclonal antibodies (mAb) make use of complement in... 
Animal models | Complement inhibitors | Target recognition | Hematology | Toxicity | Medical treatment | Immunoglobulin G | Medical services | Cytotoxicity | Activation | Complement | Optimization | Complement component C1q | Complement activation | Immunotherapy | Monoclonal antibodies | Mutation | Autoimmune diseases | Life Sciences | Immunology
Journal Article